MEDIPLEX: A phase 1 study of durvalumab (D) combined with pexidartinib (P) in patients (pts) with advanced pancreatic ductal adenocarcinoma (PDAC) and colorectal cancer (CRC).

被引：42

作者：

Cassier, Philippe Alexandre

Garin, Gwenaelle

Eberst, Lauriane

Delord, Jean-Pierre

Chabaud, Sylvie

Terret, Catherine

Montane, Laure

Bidaux, Anne-Sophie

Laurent, Severine

Jaubert, Lise

Ferlay, Celine

Bernardin, Mathilde

Tabone-Eglinger, Severine

Gilles-Afchain, Laurence

Menetrier-Caux, Christine

Caux, Christophe

Treilleux, Isabelle

Perol, David

Gomez-Roca, Carlos Alberto

机构：

[1] Ctr Leon Berard, Lyon, France

[2] Univ Claude Bernard Lyon 1, Med Oncol Dept, Ctr Leon Berard, Lyon, France

[3] Inst Univ Canc Toulouse, Toulouse, France

[4] Ctr Leon Berard, GINECO, Lyon, France

[5] Ctr Leon Berard, Lyon, France

[6] Inst Claudius Regaud, Toulouse, France

来源：

关键词：

D O I：

10.1200/JCO.2019.37.15_suppl.2579

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2579

引用

页数：2